ShadowBuys

Lobbying disclosures · Lobbying report

AMGN: third_quarter 2026 lobbying report

Monitor healthcare regulations and statutes and educate members of Congress on issues with regard to client's interests

Follow AMGN
Became public
Oct 22, 2026, 2:29 PM EDT
Event / period date
Not stated
Collected
Nov 8, 2026, 11:40 AM EST

Why this is connected

Exact legal-name match: AMGEN INC (https://www.sec.gov/Archives/edgar/data/318154/).

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/1e21d119-8915-46fd-985f-884cbef5823b/","filing_uuid":"1e21d119-8915-46fd-985f-884cbef5823b","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/1e21d119-8915-46fd-985f-884cbef5823b/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Michael Lamoureux","dt_posted":"2026-10-22T14:29:24-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"3112 Honeysuckle Lane","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Russellville","registrant_state":"AR","registrant_zip":"72801","registrant":{"id":401110643,"url":"https://lda.gov/api/v1/registrants/401110643/","house_registrant_id":null,"name":"MICHAEL J. LAMOUREUX","description":null,"address_1":"3112 Honeysuckle Lane","address_2":null,"address_3":null,"address_4":null,"city":"Russellville","state":"AR","state_display":"Arkansas","zip":"72801","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAEL J. LAMOUREUX","contact_telephone":"+1 479-886-2277","dt_updated":"2026-05-27T11:25:09.137414-04:00"},"client":{"id":73540,"url":"https://lda.gov/api/v1/clients/73540/","client_id":73540,"name":"AMGEN INC.","general_description":"Biotechnology","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-06-12"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Monitor healthcare regulations and statutes and educate members of Congress on issues with regard to client's interests","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":153986,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"LAMOUREUX","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in AMGN

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.